Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas

Pathology

Volumn 41, Issue 5, 2009, Pages 484-487

  Kim, Min Sung ^a   Oh, Ji Eun ^a   Min, Chang Ki ^a   Lee, Seok ^a   Chung, Nak Gyun ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Apoptosis; CASP10; Caspase 10; Leukaemia; Mutation

Indexed keywords

ARGININE; CASPASE 10; CYSTEINE; DEATH RECEPTOR; LEUCINE; MESSENGER RNA; PROLINE; PROTEINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MUTANT; MUTATIONAL ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 70350650808     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903041143     Document Type: Article

References (27)

1. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000; 39: 1415-1430
2. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365
3. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1996; 6: 1028-1042
4. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 1999; 6: 1060-1066
5. Vincenz C, Dixit VM. Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem 1997; 272: 6578-6583
6. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98: 47-58.
7. Leithäser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the new grow factor/ tumor necrosis receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69: 415-429
8. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF- 7, breast cancer cells. Oncol Rep 1999; 6: 33-37
9. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999; 59: 2995-3002.
10. Soung YH, Lee JW, Kim HS, et al. Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003; 22: 8048-8052
11. Kim HS, Lee JW, Soung YH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125: 708-715
12. Soung YH, Lee JW, Kim SY, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005; 65: 815-821
13. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen PA. CASP-8 mutation recognized by cytotoxic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997; 186: 785-793
14. Shin MS, Kim HS, Kang CS, et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002; 99: 4094-4099
15. Beltinger C, Kurz E, Bohler T, Schrappe M, Ludwig WD, Debatin KM. CD 95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 1998; 91: 3943-3951 (Pubitemid 28225764)
16. LandowskyTH,QuN,Buyuksal I, Painter JS, DaltonWS.Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997; 90: 4266-4270
17. Ng PW, Porter AG, Janicke RU. Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10. J Biol Chem 1999; 274: 10301-10308
18. Jeong EG, Kim MS, Nam HK, et al. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res 2008; 14: 3716-3721
19. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-1349
20. Grønbæk K, Straten PT, Ralfkiaer E, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood 1998; 92: 3018-3024
21. Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th ed. New York: Freeman, 2002; 18-40.
22. Soung YH, Lee JW, Kim SY, et al. Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch 2005; 446: 483-488
23. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954
24. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310
25. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001; 20: 5865-5877
26. Palmerini F, Devilard E, Jarry A, Birg F, Xerri L. Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001; 32: 461-467
27. Yoo NJ, Kim HS, Kim SY, et al. Stomach cancer highly expresses both initiator and Effector caspases; an immunohistochemical study. APMIS 2002; 110: 825-832